Scientific Industries INC Form 4 insider transactions

OTC.Pink
Director John Nicols reports acquisition of Scientific Industries Inc. shares and warrants.
OTC.Pink
Reginald Averilla, CFO of Scientific Industries, acquired 9,768 stock options on April 1, 2024, as part of an agreement to receive stock options in lieu of cash compensation.
OTC.Pink
Director Christopher Cox elected to receive stock options in lieu of cash compensation for board service, acquiring 17,964 options on April 1, 2024.
OTC.Pink
Christopher Cox, a director of Scientific Industries Inc., recently acquired shares and warrants, increasing his beneficial ownership in the company.
OTC.Pink
Michael Blechman, a director at Scientific Industries, acquired options to purchase common stock as part of an agreement to receive fees in lieu of cash compensation.
OTC.Pink
CEO Helena Santos elected to receive stock options in lieu of cash compensation, according to a recent SEC filing.
OTC.Pink
John Moore, a director at Scientific Industries Inc., acquired options to purchase 58,182 shares of common stock as part of an agreement to receive stock options in lieu of cash compensation.
OTC.Pink
John Moore, a director of Scientific Industries Inc., recently acquired additional shares of the company's common stock through open market purchases.